| Entry |
|
|---|
| Name |
Evogliptin (INN) |
|---|
| Formula |
C19H26F3N3O3
|
|---|
| Exact mass |
401.1926
|
|---|
| Mol weight |
401.42
|
|---|
| Structure |
|
|---|
| Class |
|
|---|
| Remark |
|
|---|
| Efficacy |
Antidiabetic, Dipeptidyl peptidase-4 (DPP-4) inhibitor |
|---|
| Target |
|
|---|
| Pathway |
| hsa04974 | Protein digestion and absorption |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
A10BH07 Evogliptin
D11023 Evogliptin (INN)
Drug groups [BR:br08330]
Antidiabetic agent
DG02044 Hypoglycemic agent
DG01601 DPP-4 inhibitor
D11023 Evogliptin
Target-based classification of drugs [BR:br08310]
Peptidases and inhibitors
Serine peptidases
Prolyl oligopeptidase family
DPP4 (CD26)
D11023 Evogliptin (INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 28
1 C5x C 23.9400 -17.9200
2 N1x N 23.9400 -19.3200
3 C1x C 22.7500 -20.0200
4 C1x C 21.4900 -19.3200
5 N1y N 21.4900 -17.9200
6 C1y C 22.7500 -17.2200
7 C5a C 20.3000 -17.2200
8 C1b C 19.1100 -17.9200
9 C1c C 17.9200 -17.2200
10 C1b C 16.7300 -17.9200
11 C8y C 15.5400 -17.2200
12 O5a O 20.3000 -15.8200
13 C8y C 14.3500 -17.9200
14 C8x C 13.0900 -17.2200
15 C8y C 13.0900 -15.8200
16 C8y C 14.2800 -15.1200
17 C8x C 15.5400 -15.8200
18 X F 11.9000 -15.1200
19 X F 14.3500 -19.3200
20 X F 14.2800 -13.7200
21 N1a N 17.9200 -15.8200
22 C1b C 22.7500 -15.8200
23 O2a O 23.9400 -15.1200
24 C1d C 23.9400 -13.7200
25 O5x O 25.1300 -17.2200
26 C1a C 22.5400 -13.7200
27 C1a C 25.3400 -13.7200
28 C1a C 23.9400 -12.3200
BOND 29
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 5 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 10 11 1
12 7 12 2
13 11 13 2
14 13 14 1
15 14 15 2
16 15 16 1
17 16 17 2
18 11 17 1
19 15 18 1
20 13 19 1
21 16 20 1
22 9 21 1 #Up
23 6 22 1 #Down
24 22 23 1
25 23 24 1
26 1 25 2
27 24 26 1
28 24 27 1
29 24 28 1
|
|---|
